{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:59:10Z","timestamp":1783339150318,"version":"3.54.6"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics Open"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s41669-018-0093-0","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T13:37:04Z","timestamp":1536068224000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids\u2019 Inpatient Database (KID)"],"prefix":"10.1007","volume":"3","author":[{"given":"Jessica","family":"Cardenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Menier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjet D.","family":"Heitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Sproule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"93_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of\u2009>\u200972,400 specimens. Eur J Hum Genet. 2012;20:27\u201332.","journal-title":"Eur J Hum Genet"},{"key":"93_CR2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, et al. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy\u2014a literature review. Orphanet J Rare Dis. 2017;12:124.","journal-title":"Orphanet J Rare Dis."},{"key":"93_CR3","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","volume":"83","author":"RS Finkel","year":"2014","unstructured":"Finkel RS, McDermott MP, Kaufmann P, et al. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology. 2014;83:810\u20137.","journal-title":"Neurology"},{"key":"93_CR4","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22:1027\u201349.","journal-title":"J Child Neurol"},{"key":"93_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/1756285610369026","volume":"3","author":"DM Sproule","year":"2010","unstructured":"Sproule DM, Kaufmann P. Therapeutic developments in spinal muscular atrophy. Ther Adv Neurol Disord. 2010;3:173\u201385.","journal-title":"Ther Adv Neurol Disord."},{"key":"93_CR6","first-page":"113","volume":"6","author":"G Haaker","year":"2013","unstructured":"Haaker G, Fujak A. Proximal spinal muscular atrophy: current orthopedic perspective. Appl Clin Genet. 2013;6:113\u201320.","journal-title":"Appl Clin Genet."},{"key":"93_CR7","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1212\/01.wnl.0000290830.40544.b9","volume":"69","author":"M Oskoui","year":"2007","unstructured":"Oskoui M, Levy G, Garland CJ, et al. The changing natural history of spinal muscular atrophy type 1. Neurology. 2007;69:1931\u20136.","journal-title":"Neurology."},{"key":"93_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1378\/chest.126.3.831","volume":"126","author":"C Ioos","year":"2004","unstructured":"Ioos C, Leclair-Richard D, Mrad S, et al. Respiratory capacity course in patients with infantile spinal muscular atrophy. Chest. 2004;126:831\u20137.","journal-title":"Chest"},{"key":"93_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.nmd.2016.10.002","volume":"26","author":"R Sanctis De","year":"2016","unstructured":"De Sanctis R, Coratti G, Pasternak A, et al. Developmental milestones in type I spinal muscular atrophy. Neuromuscul Disord: NMD. 2016;26:754\u20139.","journal-title":"Neuromuscul Disord: NMD."},{"key":"93_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-017-0695-0","volume":"12","author":"J Lopez-Bastida","year":"2017","unstructured":"Lopez-Bastida J, Pena-Longobardo LM, Aranda-Reneo I, et al. Social\/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain. Orphanet J Rare Dis. 2017;12:141.","journal-title":"Orphanet J Rare Dis."},{"key":"93_CR11","volume-title":"Treatment patterns and cost of care among patients with spinal muscular atrophy","author":"PB Shieh","year":"2017","unstructured":"Shieh PB, Gu T, Chen E, et al. Treatment patterns and cost of care among patients with spinal muscular atrophy. Orlando: Cure SMA; 2017."},{"key":"93_CR12","doi-asserted-by":"crossref","unstructured":"Teynor M, Hou Q, Zhou J, et al. Healthcare Resource Use in Patients with Diagnosis of Spinal Muscular Atrophy (SMA) in Optum\u2122 U.S. Claims Database (P4.158). Neurology. 2017. pp. 88.","DOI":"10.1212\/WNL.88.16_supplement.P4.158"},{"key":"93_CR13","doi-asserted-by":"crossref","unstructured":"Teynor M, Zhou J, Hou Q, et al. Retrospective analysis of healthcare resource utilization (HRU) in patients with spinal muscular atrophy (SMA) in MarketScan\u00ae (P3.186). Neurology. 2017. pp. 88.","DOI":"10.1212\/WNL.88.16_supplement.P3.186"},{"key":"93_CR14","doi-asserted-by":"publisher","first-page":"e0151800","DOI":"10.1371\/journal.pone.0151800","volume":"11","author":"MB Callan","year":"2016","unstructured":"Callan MB, Haskins ME, Wang P, et al. Successful phenotype improvement following gene therapy for severe hemophilia a in privately owned dogs. PLoS One. 2016;11:e0151800.","journal-title":"PLoS One"},{"key":"93_CR15","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.ymthe.2017.09.003","volume":"25","author":"JR Mendell","year":"2017","unstructured":"Mendell JR. Reply to letter to the editor. Mol Ther. 2017;25:2238\u201340.","journal-title":"Mol Ther"},{"key":"93_CR16","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1080\/13696998.2016.1198355","volume":"19","author":"EP Armstrong","year":"2016","unstructured":"Armstrong EP, Malone DC, Yeh WS, et al. The economic burden of spinal muscular atrophy. J Med Econ. 2016;19:822\u20136.","journal-title":"J Med Econ."},{"key":"93_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-016-0424-0","volume":"11","author":"C Klug","year":"2016","unstructured":"Klug C, Schreiber-Katz O, Thiele S, et al. Disease burden of spinal muscular atrophy in Germany. Orphanet J Rare Dis. 2016;11:58.","journal-title":"Orphanet J Rare Dis."},{"key":"93_CR18","volume-title":"Longitudinal results from the NeuroNeXT SMA infant biomarker study","author":"SJ Kolb","year":"2016","unstructured":"Kolb SJ. Longitudinal results from the NeuroNeXT SMA infant biomarker study. Anaheim: CureSMA Annual Meeting; 2016."},{"key":"93_CR19","unstructured":"HCUP Kids\u2019 Inpatient Database (KID). Healthcare cost and utilization project (HCUP). 2012. Agency for Healthcare Research and Quality, Rockville, MD. 2012."},{"key":"93_CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1542\/peds.106.S1.205","volume":"106","author":"C Feudtner","year":"2000","unstructured":"Feudtner C, Christakis DA, Connell FA. Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980\u20131997. Pediatrics. 2000;106:205\u20139.","journal-title":"Pediatrics"},{"key":"93_CR21","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/journalofethics.2015.17.11.stas1-1511","volume":"17","author":"V Arora","year":"2015","unstructured":"Arora V, Moriates C, Shah N. The challenge of understanding health care costs and charges. AMA J Ethics. 2015;17:1046\u201352.","journal-title":"AMA J Ethics."},{"key":"93_CR22","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1097\/PCC.0b013e3182388ad1","volume":"13","author":"TJ Lemoine","year":"2012","unstructured":"Lemoine TJ, Swoboda KJ, Bratton SL, et al. Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival? Pediatr Crit Care Med. 2012;13:e161\u20135.","journal-title":"Pediatr Crit Care Med."},{"key":"93_CR23","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s00467-010-1625-8","volume":"25","author":"JD Spencer","year":"2010","unstructured":"Spencer JD, Schwaderer A, McHugh K, et al. Pediatric urinary tract infections: an analysis of hospitalizations, charges, and costs in the USA. Pediatr Nephrol. 2010;25:2469\u201375.","journal-title":"Pediatr Nephrol."},{"issue":"1127\u201333","key":"93_CR24","first-page":"e3","volume":"163","author":"K Hasegawa","year":"2013","unstructured":"Hasegawa K, Tsugawa Y, Brown DF, et al. Childhood asthma hospitalizations in the United States, 2000\u20132009. J Pediatr. 2013;163(1127\u201333):e3.","journal-title":"J Pediatr."}],"container-title":["PharmacoEconomics - Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-018-0093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s41669-018-0093-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s41669-018-0093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T22:47:33Z","timestamp":1720565253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s41669-018-0093-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["93"],"URL":"https:\/\/doi.org\/10.1007\/s41669-018-0093-0","relation":{},"ISSN":["2509-4262","2509-4254"],"issn-type":[{"value":"2509-4262","type":"print"},{"value":"2509-4254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"4 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was supported by AveXis, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Jessica Cardenas, Melissa Menier, and Douglas M. Sproule are current or former employees of AveXis, Inc. Marjet D. Heitzer is a contract medical writer for AveXis, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}